Davide Campari Milano NV
MIL:CPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
Yunnan Yuntianhua Co Ltd
SSE:600096
|
CN |
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
Discovex Resources Ltd
ASX:DCX
|
AU |
|
S
|
Steakholder Foods Ltd
NASDAQ:STKH
|
IL |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Comfortdelgro Corporation Ltd
SGX:C52
|
SG |
Wall St Price Targets
CPR Price Targets Summary
Davide Campari Milano NV
According to Wall Street analysts, the average 1-year price target for CPR is 7.127 EUR with a low forecast of 5.353 EUR and a high forecast of 10.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CPR's stock price target?
Price Target
7.127
EUR
According to Wall Street analysts, the average 1-year price target for CPR is 7.127 EUR with a low forecast of 5.353 EUR and a high forecast of 10.71 EUR.
What is the Revenue forecast for Davide Campari Milano NV?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Davide Campari Milano NV?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Davide Campari Milano NV?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 5 years is 13%.
